EP Patent

EP1809237B1 — Ophthalmic oil-in-water type emulsion with stable positive zeta potential

Assigned to Santen Sas · Expires 2008-12-31 · 17y expired

What this patent protects

Patent listed against Sandimmune.

Drugs covered by this patent

Patent Metadata

Patent number
EP1809237B1
Jurisdiction
EP
Classification
—
Expires
2008-12-31
Drug substance claim
No
Drug product claim
No
Assignee
Santen Sas
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.